Lyu Yun-Xiao, Cheng Yun-Xiao, Jin Hang-Fei, Jin Xin, Cheng Bin, Lu Dian
Department of Hepatobiliary Surgery, Dongyang People's Hospital, 60 West Wuning Road, 322100, Dongyang, Zhejiang, China.
BMC Surg. 2018 Nov 29;18(1):111. doi: 10.1186/s12893-018-0445-9.
The timing of laparoscopic cholecystectomy (LC) performed after the mild acute biliary pancreatitis (MABP) is still controversial. We conducted a review to compare same-admission laparoscopic cholecystectomy (SA-LC) and delayed laparoscopic cholecystectomy (DLC) after mild acute biliary pancreatitis (MABP).
We systematically searched several databases (PubMed, EMBASE, Web of Science, and the Cochrane Library) for relevant trials published from 1 January 1992 to 1 June 2018. Human prospective or retrospective studies that compared SA-LC and DLC after MABP were included. The measured outcomes were the rate of conversion to open cholecystectomy (COC), rate of postoperative complications, rate of biliary-related complications, operative time (OT), and length of stay (LOS). The meta-analysis was performed using Review Manager 5.3 software (The Cochrane Collaboration, Oxford, United Kingdom).
This meta-analysis involved 1833 patients from 4 randomized controlled trials and 7 retrospective studies. No significant differences were found in the rate of COC (risk ratio [RR] = 1.24; 95% confidence interval [CI], 0.78-1.97; p = 0.36), rate of postoperative complications (RR = 1.06; 95% CI, 0.67-1.69; p = 0.80), rate of biliary-related complications (RR = 1.28; 95% CI, 0.42-3.86; p = 0.66), or OT (RR = 1.57; 95% CI, - 1.58-4.72; p = 0.33) between the SA-LC and DLC groups. The LOS was significantly longer in the DLC group (RR = - 2.08; 95% CI, - 3.17 to - 0.99; p = 0.0002). Unexpectedly, the subgroup analysis showed no significant difference in LOS according to the Atlanta classification (RR = - 0.40; 95% CI, - 0.80-0.01; p = 0.05). The gallstone-related complications during the waiting time in the DLC group included gall colic, recurrent pancreatitis, acute cholecystitis, jaundice, and acute cholangitis (total, 25.39%).
This study confirms the safety of SA-LC, which could shorten the LOS. However, the study findings have a number of important implications for future practice.
轻度急性胆源性胰腺炎(MABP)后行腹腔镜胆囊切除术(LC)的时机仍存在争议。我们进行了一项综述,以比较轻度急性胆源性胰腺炎(MABP)后同期腹腔镜胆囊切除术(SA-LC)和延迟腹腔镜胆囊切除术(DLC)。
我们系统检索了几个数据库(PubMed、EMBASE、科学网和考克兰图书馆),以查找1992年1月1日至2018年6月1日发表的相关试验。纳入比较MABP后SA-LC和DLC的人类前瞻性或回顾性研究。测量的结果包括转为开腹胆囊切除术(COC)的发生率、术后并发症发生率、胆源性并发症发生率、手术时间(OT)和住院时间(LOS)。使用Review Manager 5.3软件(英国牛津考克兰协作组织)进行荟萃分析。
这项荟萃分析涉及来自4项随机对照试验和7项回顾性研究的1833例患者。SA-LC组和DLC组在COC发生率(风险比[RR]=1.24;95%置信区间[CI],0.78-1.97;p=0.36)、术后并发症发生率(RR=1.06;95%CI,0.67-1.69;p=0.80)、胆源性并发症发生率(RR=1.28;95%CI,0.42-3.86;p=0.66)或OT(RR=1.57;95%CI,-1.58-4.72;p=0.33)方面未发现显著差异。DLC组的住院时间明显更长(RR=-2.08;95%CI,-3.17至-0.99;p=0.0002)。出乎意料的是,亚组分析显示根据亚特兰大分类法,住院时间无显著差异(RR=-0.40;95%CI,-0.80-0.01;p=0.05)。DLC组等待期间与胆结石相关的并发症包括胆绞痛、复发性胰腺炎、急性胆囊炎、黄疸和急性胆管炎(总计25.39%)。
本研究证实了SA-LC的安全性,其可缩短住院时间。然而,研究结果对未来的实践有许多重要意义。